Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The efficacy and safety of etanercept when used with as-needed adjunctive topical therapy in a randomised, double-blind study in subjects with moderate-to-severe psoriasis (the PRISTINE trial).
Strohal R, Puig L, Chouela E, Tsai TF, Melin J, Freundlich B, Molta CT, Fuiman J, Pedersen R, Robertson D. Strohal R, et al. Among authors: molta ct. J Dermatolog Treat. 2013 Jun;24(3):169-78. doi: 10.3109/09546634.2012.658015. Epub 2012 Feb 23. J Dermatolog Treat. 2013. PMID: 22251226 Clinical Trial.
Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study.
Daudén E, Griffiths CE, Ortonne JP, Kragballe K, Molta CT, Robertson D, Pedersen R, Estojak J, Boggs R. Daudén E, et al. Among authors: molta ct. J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1374-82. doi: 10.1111/j.1468-3083.2009.03321.x. Epub 2009 Jun 26. J Eur Acad Dermatol Venereol. 2009. PMID: 19563497 Clinical Trial.
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page